The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.addr.2018.03.004PMID 29627371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

  2020cited by this paper
• Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.

  2017cited by this paper
• Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.

  2017cited by this paper
• Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

  2017cited by this paper
• Fibroblasts and extracellular matrix: Targeting and therapeutic tools in fibrosis and cancer.

  2017cited by this paper
• Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer

  2017cited by this paper
• Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis

  2017cited by this paper
• Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

  2017cited by this paper
• Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis

  2017cited by this paper
• Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.

  2017cited by this paper
• Detrimental role of lysyl oxidase in cardiac remodeling.

  2017cited by this paper
• Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX.

  2017cited by this paper
• Drug targeting to myofibroblasts: Implications for fibrosis and cancer

  2017cited by this paper
• Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease

  2017cited by this paper
• TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice

  2017cited by this paper
• Collagen cross-linking: insights on the evolution of metazoan extracellular matrix

  2016cited by this paper
• Extracellular matrix structure.

  2016cited by this paper
• Lysyl oxidase promotes epithelial-to-mesenchymal transition during paraquat-induced pulmonary fibrosis.

  2016cited by this paper
• An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer.

  2016cited by this paper
• Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment

  2016cited by this paper
• Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis

  2016cited by this paper
• Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

  2016cited by this paper
• Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease

  2016cited by this paper
• Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis.

  2016cited by this paper
• Proteases in cancer drug delivery.

  2016cited by this paper
• Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis

  2016cited by this paper
• A single adenovirus‐mediated relaxin delivery attenuates established liver fibrosis in rats

  2016cited by this paper
• Simtuzumab treatment of advanced liver fibrosis in HIV and HCV‐infected adults: results of a 6‐month open‐label safety trial

  2016cited by this paper
• ADAM17 substrate release in proximal tubule drives kidney fibrosis.

  2016cited by this paper
• Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix.

  2016cited by this paper
• EMT: 2016.

  2016cited by this paper
• Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells

  2016cited by this paper
• Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model

  2016cited by this paper
• Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis

  2016cited by this paper
• Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition

  2016cited by this paper
• Lysyl Oxidase and the Tumor Microenvironment

  2016cited by this paper
• MMP-9 1562C>T Gene Polymorphism and Efficacy of Glucocorticoid Therapy in Idiopathic Pulmonary Fibrosis Patients

  2015cited by this paper
• Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis

  2015cited by this paper
• Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

  2015cited by this paper
• A new role for LOX and LOXL2 proteins in transcription regulation

  2015cited by this paper
• Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro

  2015cited by this paper
• Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis*

  2015cited by this paper
• ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation

  2014cited by this paper
• Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition

  2014cited by this paper
• Mononuclear Phagocytes and Airway Epithelial Cells: Novel Sources of Matrix Metalloproteinase-8 (MMP-8) in Patients with Idiopathic Pulmonary Fibrosis

  2014cited by this paper
• Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization

  2014cited by this paper
• Brief Report: Lysyl Oxidase Is a Potential Biomarker of Fibrosis in Systemic Sclerosis

  2014cited by this paper
• Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

  2014cited by this paper
• Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl4-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression

  2014cited by this paper
• Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis

  2014cited by this paper
• Lysyl oxidase promotes bleomycin-induced lung fibrosis through modulating inflammation.

  2014cited by this paper
• Cysteine cathepsins and their potential in clinical therapy and biomarker discovery

  2014cited by this paper
• Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.

  2014cited by this paper
• Pivotal Role of Matrix Metalloproteinase 13 in Extracellular Matrix Turnover in Idiopathic Pulmonary Fibrosis

  2013cited by this paper
• Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.

  2013cited by this paper
• Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage

  2013cited by this paper
• Unraveling hidden regulatory sites in structurally homologous metalloproteases.

  2013cited by this paper
• LOXL4 Is Induced by Transforming Growth Factor β1 through Smad and JunB/Fra2 and Contributes to Vascular Matrix Remodeling

  2013cited by this paper
• Vitamin C: a wound healing perspective.

  2013cited by this paper
• Lysyl oxidase in colorectal cancer.

  2013cited by this paper
• Kidney tubular β-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication

  2013cited by this paper
• MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays

  2013cited by this paper
• Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury.

  2013cited by this paper
• Profibrotic Activities for Matrix Metalloproteinase-8 during Bleomycin-Mediated Lung Injury

  2013cited by this paper
• Long-term Outcomes After Surgery on Pediatric Patients With Crohn Disease

  2013cited by this paper
• Liver fibrosis: a bidirectional model of fibrogenesis and resolution.

  2012cited by this paper
• Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia

  2012cited by this paper
• The rationale for targeting the LOX family in cancer

  2012cited by this paper
• Syndecan-2 Is a Novel Target of Insulin-Like Growth Factor Binding Protein-3 and Is Over-Expressed in Fibrosis

  2012cited by this paper
• Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.

  2012cited by this paper
• Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage

  2012cited by this paper
• Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes.

  2012cited by this paper
• The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

  2012cited by this paper
• Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney

  2012cited by this paper
• The Glial Scar-Monocyte Interplay: A Pivotal Resolution Phase in Spinal Cord Repair

  2011cited by this paper
• Peripheral Blood Based Discrimination of Ulcerative Colitis and Crohn’s Disease from Non-IBD Colitis by Genome-Wide Gene Expression Profiling

  2011cited by this paper
• Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice.

  2011cited by this paper
• The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis

  2011cited by this paper
• Loss of Matrix Metalloproteinase-2 Amplifies Murine Toxin-Induced Liver Fibrosis by Upregulating Collagen I Expression

  2011cited by this paper
• Cellular and molecular mechanisms of renal fibrosis

  2011cited by this paper
• Cardiovascular , Pulmonary , and Renal Pathology Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis

  2011cited by this paper
• Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

  2011cited by this paper
• Matrix Metalloproteinase-13 Promotes Recovery from Experimental Liver Cirrhosis in Rats

  2011cited by this paper
• Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

  2011cited by this paper
• Matrilysin‐1 (MMP7) cleaves galectin‐3 and inhibits wound healing in intestinal epithelial cells

  2011cited by this paper
• Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain.

  2011cited by this paper
• Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases.

  2011cited by this paper
• Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential

  2011cited by this paper
• The extracellular matrix in development and morphogenesis: a dynamic view.

  2010cited by this paper
• Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis

  2010cited by this paper
• Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor

  2010cited by this paper
• The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin

  2010cited by this paper
• Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?

  2010cited by this paper
• Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

  2010cited by this paper
• Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

  2010cited by this paper
• Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing.

  2010cited by this paper
• Association of a Functional Polymorphism in the Matrix Metalloproteinase-12 Promoter Region with Systemic Sclerosis in an Italian Population

  2010cited by this paper
• Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.

  2010cited by this paper
• Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1′ Loop Canonical Conformation*

  2010cited by this paper
• Macrophages: Master Regulators of Inflammation and Fibrosis

  2010cited by this paper

• Fibroblast-Targeted Nanodelivery Systems: Mechanisms of Collagen Remodeling Regulation and Novel Strategies for Scar Repair.

  2026cites this paper
• Airway basal stem cell-derived extracellular vesicles modulate proliferation, migration and collagen deposition of fibroblasts

  2025cites this paper
• Extracellular matrix and proteolysis: mechanisms driving irreversible changes and shaping cell behavior.

  2025cites this paper
• Bioengineered Decellularized Extracellular Matrices in Diabetic Ulcer Therapy: Therapeutic and Clinical Outlook

  2025cites this paper
• A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer.

  2025cites this paper
• Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis

  2025cites this paper
• Integrative single-cell and machine learning approach to characterize immunogenic cell death and tumor microenvironment in LUAD

  2025cites this paper
• The potential therapeutic role of ginsenosides on fibrosis-associated diseases: a review on molecular mechanisms and call for further research.

  2025cites this paper
• Bone marrow-targeted LOXL2 inhibitor-loaded yolk-shell nanoparticle overcomes extracellular matrix-mediated chemotherapy resistance in acute myeloid leukemia.

  2025cites this paper
• Matrix Dynamics and Microbiome Crosstalk: Matrix Metalloproteinases as Key Players in Disease and Therapy

  2025cites this paper
• Exploring the role of LOX family in glioma progression and immune modulation

  2025cites this paper
• Tetrahedral DNA loaded siCCR2 restrains M1 macrophage polarization to ameliorate pulmonary fibrosis in chemoradiation-induced murine model

  2024cites this paper
• Decellularized Cell‐Secreted Extracellular Matrices as Biomaterials for Tissue Engineering

  2024cites this paper
• Ethyl butyrate inhibits caudal fin regeneration in adult zebrafish by disrupting extracellular matrix remodeling.

  2024cites this paper
• Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression

  2024cites this paper
• Potential of Graphene-Functionalized Polymer Surfaces for Dental Applications: A Systematic review

  2024cites this paper
• Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment.

  2024cites this paper
• Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease

  2024cites this paper
• Exploring Extracellular Matrix Crosslinking as a Therapeutic Approach to Fibrosis

  2024cites this paper
• Pterostilbene: a potential therapeutic agent for fibrotic diseases

  2024cites this paper
• The role of matrix stiffness in breast cancer progression: a review

  2023cites this paper
• Hypoxia preconditioned DPSC-derived exosomes regulate angiogenesis via transferring LOXL2.

  2023cites this paper
• Digital light processing-bioprinted poly-NAGA-GelMA-based hydrogel lenticule for precise refractive errors correction

  2023cites this paper
• Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways

  2023cites this paper
• Alignment, cross-linking, and beyond: A collagen architect's guide to the skeletal muscle extracellular matrix.

  2023cites this paper
• Macrophage-Associated Disorders: Pathophysiology, Treatment Challenges, and Possible Solutions

  2022cites this paper
• A Case-control Study to Determine Metalloproteinase-12 and Lysyl Oxidase Levels in Iraqi women with Osteoporosis

  2022cites this paper
• Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies

  2022influential citation
• Diverse effector and regulatory functions of fibro/adipogenic progenitors during skeletal muscle fibrosis in muscular dystrophy

  2022cites this paper
• Cold exposure and capsaicin promote 1,2-dimethylhyrazine-induced colon carcinogenesis in rats correlates with extracellular matrix remodeling

  2021cites this paper
• Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression

  2021cites this paper
• LncRNA-PVT1 activates lung fibroblasts via miR-497-5p and is facilitated by FOXM1.

  2021cites this paper
• Protective effects of total flavonoids from Qu Zhi Qiao (fruit of Citrus paradisi cv. Changshanhuyou) on OVA-induced allergic airway inflammation and remodeling through MAPKs and Smad2/3 signaling pathway.

  2021cites this paper
• Xinyang Tablet Inhibits MLK3-mediated Pyroptosis to Attenuate Inflammation and Cardiac Dysfunction in Pressure Overload.

  2021cites this paper
• Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer

  2021cites this paper
• The inflammatory speech of fibroblasts

  2021cites this paper
• Transcriptome sequencing analysis of primary fibroblasts: a new insight into postoperative abdominal adhesion

  2021cites this paper
• Adipose Collagen Fragment: an Injectable Sustained-release Collagen Scaffold of Adipokines for Preventing Skin Photoaging in Mice

  2021influential citation
• An Adipose-Derived Injectable Sustained-Release Collagen Scaffold of Adipokines Prepared Through a Fast Mechanical Processing Technique for Preventing Skin Photoaging in Mice

  2021influential citation
• Development of Anti-fibrotic Therapy in Stricturing Crohn's Disease: Lessons from Randomized Trials in Other Fibrotic Diseases.

  2021cites this paper
• Sex-Based Differences in the Tumor Microenvironment.

  2021cites this paper
• VITREOUS AND VISION DEGRADING MYODESOPSIA.

  2020cites this paper
• Towards extracellular matrix normalization for improved treatment of solid tumors

  2020cites this paper
• Expression and Potential Role of MMP-9 in Intrauterine Adhesion

  2020cites this paper
• Expressions of extracellular matrix-remodeling factors in lymph nodes from oral cancer patients.

  2020cites this paper
• Downregulation of lysyl oxidase in venous malformations: Association with vascular destabilization and sclerotherapy

  2020cites this paper
• Dual-Responsive Size-Shrinking Nanocluster with Hierarchical Disassembly Capability for Improved Tumor Penetration and Therapeutic Efficacy.

  2019cites this paper
• Novel Approaches for Extracellular Matrix Targeting in Disease Treatment.

  2019cites this paper
• from targeting the as a strategy.

  2019cites this paper
• Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases.

  2019cites this paper
• LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells

  2019cites this paper
• Over-Expression of Inhibitor of Differentiation 2 Attenuates Post-Infarct Cardiac Fibrosis Through Inhibition of TGF-β1/Smad3/HIF-1α/IL-11 Signaling Pathway

  2019cites this paper
• Lysyl oxidases: from enzyme activity to extracellular matrix cross-links.

  2019cites this paper
• Wound healing and scarring are highly conserved physiological responses to wounding in most tissues in higher organisms, consisting of a sequence of well-characterised stages (coagulation, inflammation, proliferation and remodelling [1-3]), with the aim to repair interrupted tissue structures and to

  2019cites this paper
• Withaferin A reverses bile duct ligation-induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling.

  2019cites this paper
• Transient receptor potential ion-channel subfamily V member 4: a potential target for cancer treatment

  2019cites this paper
• Signaling pathways involved in p38-ERK and inflammatory factors mediated the anti-fibrosis effect of AD-2 on thioacetamide-induced liver injury in mice.

  2019cites this paper
• Redox signaling in aging kidney and opportunity for therapeutic intervention through natural products.

  2019cites this paper
• The extracellular matrix as a multitasking player in disease

  2019cites this paper
• Wound healing and scar wars.

  2018cites this paper
• Identifying a Membrane-Type 2 Matrix Metalloproteinase-Targeting Peptide for Human Lung Cancer Detection and Targeting Chemotherapy with Functionalized Mesoporous Silica.

  2018cites this paper